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INTRODUCTION
 HIV infection has increased the burden of
tuberculosis, especially in populations where HIV
has become common, and where the prevalence of
tuberculosis infection is high 1,2. It is estimated that
worldwide, nearly two billion people are infected
with Mycobacterium tuberculosis, 36 million are HIV
infected and over 10 million are dually infected with
M.tuberculosis and HIV. Tuberculosis is the
commonest opportunistic infection occurring among
HIV positive persons in India and it is estimated that
60-70% of HIV positive persons will develop
tuberculosis in their lifetime3.  Several studies from
different parts of the country have also documented
high HIV sero-prevalence rates among tuberculosis
patients4.
Diagnosis of tuberculosis among HIV
infected persons is often delayed, and is difficult to
make since  HIV-infected persons with tuberculosis
are more likely to have negative sputum smears and
minor or non-specific X-ray abnormalities5. Among
HIV infected persons with an intact immune system,
the clinical features of tuberculosis are fairly typical;
however, these change markedly among HIV-
positive persons with severe immunodeficiency
(e.g.CD4 cell counts <200).
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Summary:
Objectives: To study the clinical, radiological and immunological profile of pulmonary tuberculosis in HIV infected
patients and assess the response to short-course chemotherapy regimens.
Methods: Seventy eight patients (68 males and 10 females) with HIV infection  and having symptoms suggestive of
tuberculosis attending the Government Hospital for Thoracic Medicine, Tambaram or the Tuberculosis Research Centre,
Chennai were studied. The diagnosis of tuberculosis was based on clinical evaluation, bacteriological examination includ-
ing sputum smear and culture and chest skiagram. HIV diagnosis was based on two tests (rapid/ELISA), detecting different
antigens. CD4+ T cell counts were done on all patients initially and at the end of treatment.
Blood tests and skiagrams were repeated at 2 months and at the end of treatment. All the patients were treated with
standard (RNTCP) short course regimens. Patients were given all the doses under supervision during the initial intensive
phase and through community DOTS providers in the continuation phase.
Results: Sixty five patients had culture confirmed pulmonary tuberculosis, of whom 54 had smear positive disease,
initially. The radiological manifestations were varied, with 11 subjects having miliary tuberculosis, 54 with non-homoge-
neous opacities and 10 with cavitation. The mean CD4 cell count at intake was 192 ± 172 cells/cumm. Patients showed
good initial response to treatment with significant weight gain. At the end of 2 months of treatment, 91% of patients had
sputum cultures negative for Mycobacterium tuberculosis. However, the CD4 % fell significantly by the sixth month.
The study is being continued to assess the long-term response to SCC of patients with HIV and tuberculosis.
Conclusions: Tuberculosis has a varied clinical presentation in patients with HIV infection. The spectrum of radiographic
features ranges from normal to a miliary pattern. Inspite of clinical and bacteriological improvement during treatment,
immunologic deterioration may continue.
Key words: Pulmonary tuberculosis, HIV infection, Clinical profile of TB/HIV patients.
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The aim of this study was to record  the clinical,
radiological and immunological profile of
pulmonary tuberculosis in HIV seropositive persons.
This preliminary report is part of a larger ongoing
clinical trial to evaluate the efficacy of short course
intermittent (RNTCP) regimens in patients with HIV
and tuberculosis.
METHODS
HIV sero-positive patients with symptoms
suggestive of pulmonary tuberculosis attending the
Outpatient Departments at Tuberculosis Research
Centre, Chennai (TRC) and Government Hospital
for Thoracic Medicine (GHTM), Tambaram were
enrolled, if they fulfilled the inclusion criteria. The
patients had to be more than 15 year old, residing in
an area within 100 kms from TRC or GHTM and
had to have no major  systemic derangement which
could cause difficulty in management. Informed
consent was taken from the patients prior to
enrolment into the study. A detailed history including
previous  anti-tuberculosis therapy, addictions &
high-risk sexual behaviour was elicited. A general
clinical examination was performed. Baseline
investigations such as chest X-ray, 3 sputum
specimens  for AFB smear, culture and drug
sensitivity and blood examination were
performed as detailed below. Tuberculin testing was
done with 1TU of PPD RT 23 and the induration
was measured after 48 to 72 hours by trained
readers.
The sputum smears were examined for AFB by
fluorescence microscopy.  The sputum specimens
were processed by modified Petroff's method and
cultured on the LJ medium. Positive cultures were
subjected to identification tests, viz Niacin
production, growth on LJ medium containing 500
mg/L of para-nitro benzoic acid and stability of
Catalase at 68°C in order to identify the organism
as Mycobacterium tuberculosis or non-tuberculous
mycobacteria. All the positive cultures were
subjected to drug susceptibility tests using standard
methods as described elsewhere6. HIV screening
was performed using the Tridot Rapid Test; all
positive results were confirmed using Comb Aids
Rapid test and also by ELISA. Hemoglobin, total
blood urea, serum creatinine, serum uric acid and
liver function tests were performed. The CD4, CD8
cell counts and CD4/CD8 ratio were determined
using flow cytometry (Simultest-IMK Lymphocyte
kit).
The diagnosed  patients were started on
anti-tuberculosis (RNTCP) regimens based on
history of previous ATT and the current sputum
smear results. Regimens used were Cat I:
2H3R3E3Z3/4H3R3, Cat II: 2S3H3R3E3Z3/
1H3R3E3Z3/5H3R3E3 and Cat-III: 2H3R3Z3/
4H3R3. Standard dosages were used and
managment of adverse reactions was  done
according to RNTCP guidelines. Treatment was
completely supervised during the initial intensive
phase and community DOTS providers were
arranged for those patients unable to attend the clinic
as required during the continuation phase. All the
patients underwent periodic monthly clinical and
sputum examination till the end of treatment, at which
time the clinical, radiological, bacteriological and
immunological parameters were re-evaluated.
RESULTS
Of the 78 patients included in this report,
68 (87%) were males and 10 (13%) were females.
Nearly one half of the patients were 31-40 years old
while 35% were 20-38 year old; 52 (67%)
patients were married and living with their spouses,
9 (11%) were either widowed or separated from
their spouses and 17(22%) were unmarried. Of the
68 males, 56 (82%) admitted to having sexually high
risk behaviour, 3(4%) had history of blood
transfusions and 1 patient was an intravenous drug
abuser. All the females, except  one, got the infection
from their husbands.  Most of the patients had a
combination of two or more symptoms at the time
of enrolment. The frequency of the salient
symptoms as reported is given in Table 1. The mean
duration of the salient symptoms prior to reporting
was 12 weeks.The salient clinical findings at the
time of enrolment are given in Table 2. Oral thrush
and generalized muscle wasting were promi-
nent features. The tuberculin test results were
available for 59 patients and the distribution is given
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Table 1: Distribution of symptoms* (N=78)
Symptoms                     Number              %
Cough 76 97
Weight loss 73 94
Fever 62 79
Dyspnoea 53 68
Chest pain 37 47
Hemoptysis 14 18
*Patients had more than 1 symptom each
Table 2: Distribution of clinical signs (N=78)
Signs Number %
Muscle wasting 37  47
Oral thrush 30 38
Lymphadenopathy 23 29
Clubbing 14 18
Pedal oedema 7 9
Respiratory Signs
Bronchial breathing 11 14
Rhonchi 11 14
Crepitations 43 55
The pre-treatment chest X-rays were
available for 66 patients; of these, 12 patients had
more than 1 radiological lesion (Table 4).
Outcome of treatment
During the course of anti-tuberculosis
therapy,several parameters were evaluated. The
mean weight at enrolment was 41.5 ± 8 kg; the
median weight was 40 kg with a range from 30 kg
to 73 kg. By the end of treatment, there was a
significant weight gain with the mean weight
increasing to 48 kg.
Of the 78 patients, 56 were started on RNTCP
Category I, 15 on Category II and 7 on Category II
regimens. In all, 65 patients had positive pre-
tretment sputum culture; 54 (83%) patients were
sear positive and 11 were smear negative. The oerall
smear conversion rate by the end of the second
month of treatment was 70% and  culture conversion
was 91%. The smear conversion on a monthly basis
is shown in  Figure 1.
Table 3: Distribution of Mantoux test
                   indurations  (N=59)
Induration     Number %
0 mm       25 42
1-5 mm         8 14
6-10 mm         2   3
11-20 mm       17
29>20mm         7 12
Total       59                   100
Table 4: Radiological lesions at presentation*
Lesion      Number %
Normal X-ray 6 9
Pleural effusion 8 12
Mediastinal glands 2 3
Pneumothorax 1 2
Opacities
   Focal U/L 6 9
   Focal L/L 9 14
   Extensive 25 38
Cavitation
   U/L 7 11
   L/L 2 3
Miliary tuberculosis 11                17
*12 patients had more than one lesion
The comparison of the immunological
parameters at the time of intake and at completion
of treatment is shown in Table 5. The mean CD4
cell count at intake was 192 + 173 cells/cu.mm with
a range of 16 to 918.  There was a progressive
decline in the CD4%, CD8% and the CD4/CD8 ratio
at the end of treatment.
DISCUSSION
Tuberculosis is the commonest
opportunistic disease in HIV positive persons in India
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and can develop at any stage  of the disease. Many
studies have given the clinical profile of tuberculosis
in HIV positive persons in USA and Africa2,7.
However, there is a paucity of such data from
India8,9. Hence, it is important to study their profile,
as it would help in making an early diagnosis.  It is
also important to study the efficacy of short course
intermittent regimens in this group, as the RNTCP
strategy covers all patients irrespective of their HIV
status5 .
 The most common presenting symptoms were
cough and loss of weight, followed by fever. The
average duration of symptoms was 12 weeks,
indicating that there was a delay in diagnosing
tuberculosis and starting treatment.  Whether the
delay was at the patient or provider level needs
further investigation. Half the patients were
emaciated and 40% had associated oral thrush,
which serves as a good clinical pointer towards HIV
infection. About 30% of patients had an associated
extra-pulmonary focus in the form of cervical or
axillary lymphadenitis, pointing to the disseminated
nature of the disease in HIV positive persons.  Half
the patients had tuberculin reaction > 5mm but there
was no correlation between CD4 counts and
Mantoux reaction.
The radiological  manifestations were varied
with the commonest lesion being exudative opacities,
which were found in 51% of the patients.  Lower
lobe lesions were more common and the disease
quite often tended to involve more lung fields in both
lungs. Only 14% of patients had cavitary lesions.
Miliary tuberculosis was the presentation in 17% of
the patients and 9% had normal X-ray    in spite of
having positive sputum cultures. Previous studies
have also reported a lower prevalence of
focal infiltrates, upper lobe infiltrates and cavitary
disease in HIV+ patients with tuberculosis7. Hence,
the diagnosis of tuberculosis has to be suspected in
HIV positive persons irrespective of the type, site
and extent of radiological lesions. Further, since
tuberculosis could be present even in persons with
a normal chest X-ray, the presence of symptoms
warrants detailed investigations.
Of the 65 cases, who had culture confirmed
pulmonary tuberculosis, 83% were smear positive
at intake. This is not very different from the situation
in HIV un-infected tuberculosis patients and indicates
that smear microscopy could be a sensitive
diagnostic tool even in the presence of HIV infection.
However, a study from New York found that smears
were AFB positive more often in
non-HIV-infected patients with pulmonary
Table 5: Immunological parameters at start and  end of treatment (N=78)
0 month P value
Lymphocyte count (cells/cu.mm) 2588 + 1100 2162 +1694 P < 0.05
CD4% 14.3 + 8.3 9.9 + 6.7 P<0.001
CD4 count (cells/cu.mm) 192 + 172 199 + 214 NS
CD8% 56.3 + 14.1 47.9 + 15.2 P<0.01
CD8 count (cells/cu.mm) 747 + 536 803 + 709 P=0.01*
CD4/CD8 ratio 0.33 ± 0.46 0.24 + 0.25 P<0.05
*t test was performed after log transformation NS = Not significant
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during treatment
Indian Journal of Tuberculosis
193
tuberculosis than in HIV-infected patients7. In our
study,  smear and culture conversion rates at 2
months were 70% and 91% respectively, indicating
good initial response to the intermittent short course
regimens used. Patients also showed significant
clinical improvement and weight gain during therapy.
However, long term follow up is required to study
relapse rates before the efficacy of these regimens
in HIV positive persons can be established, in Indian
conditions.
Patients in this study had a mean CD 4 count of
192 cells/cu.mm at baseline,  indicating advanced
HIV disease. Median CD4 cell counts in previous
reports of tuberculosis in HIV-infected patients have
ranged from < 150/cu.mm to > 300/cu.mm10-12. Our
study also demonstrates a significant decline in CD
4 %, CD 8 % and CD 4/CD 8 ratio at the end of
treatment, compared to initial values. This indicates
progressive immunosupression and is a poor
prognostic factor. It is known that tuberculosis
accelerates HIV disease progression because of
production of cytokines like TNF-a, which increase
viral replication. One-year mortality for HIV/TB
patient has been reported to be in the range of 20-
35%13-15. The higher mortality in HIV+ patients who
develop tuberculosis is mostly due to other
opportunistic infections, which occur in the presence
of profound immunosuppression.
Treatment with standard anti-tuberculosis
regimens using DOTS could go a long way in
improving the clinical condition and quality of
life of patients with HIV and tuberculosis.
However, without concomitant anti-retroviral
treatment there is continued immunologic
deterioration and progression of HIV disease.
More data are required on the efficacy of short
course intermittent regimens and their
long-term outcome including mortality in these
patients.
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LEAVES FROM HISTORY - 13
Mention has been made of some missionary and philanthropic agencies in the previous instalment
of this series (Leaves from History-12).  However, the list was by no means exhaustive and there have been
several others who contributed to the cause.
Prominent among these was the Ramakrishna Mission, which added provision of services to
tuberculosis patients to their multifarious relief activities, as early as 1933, in Delhi.  The Ramakrishna
Mission Free TB Clinic started functioning in a small rented building in the old city of Delhi and after relocating
twice, finally moved to its present premises in 1948. Almost from the beginning, the Clinic was equipped for
carrying out operations such as Artificial Pneumothorax, phrenectomy, etc. Basic laboratory and radiological
facilities were also available and all tests were done free of charge. To make home treatment effective, some
health visitors were also employed to visit patients’ houses and give preventive  advice.
Swami Sharvananda, Dr. I.T. Mittra, Dr. N.C. Joshi, Dr. S.C. Sen and Dr.S.K. Sen were among
the pioneers who nurtured the institution in its early years.
Nor was this the only non-governmental activity going on in the country.  Anti-Tuberculosis Sub-
Committees had been formed in Bangalore, Calcutta, Madras, Jullundur & Ludhiana and  nine cities in UP
in the middle thirties with official help although a record of their activities is not currently available.  It is
also of interest to note that the Bengal Tuberculosis Association (established 1928) & the UP Tuberculosis
Association (March 1939) predate the formation of the Tuberculosis Association of India (1939) and
sought affiliation only subsequently.  The early activities of the Bengal TB Association included health
education, publication of a monthly journal, running of dispensaries in Calcutta & Howrah and rendering of
assistance to several others in  Bengal & training of  TB health  visitors.   The Association had  the benefit
of advice from such stalwarts as Dr.B.C. Roy, Dr.A.C. Ukil and Dr.S. Sarbadhikari.  The UP Tuberculosis
Association carried out a Tuberculin Survey as early as 1939.
NGOs & Philanthropists in the vanguard of Anti-TB Movement in India
